Brunswick (BC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Mar, 2026Executive summary
Annual meeting scheduled for May 6, 2026, with voting available online and virtually during the meeting.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of ten nominees to the Board of Directors is up for vote.
Advisory vote on the compensation of Named Executive Officers is included.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Ten nominees are presented for election to the Board, including Nancy E. Cooper, David C. Everitt, and others.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Brunswick
- 2025 saw sales growth, strong cash flow, and robust governance, with all proposals up for shareholder vote.BC
Proxy filing19 Mar 2026 - 2026 outlook: $5.6B–$5.8B revenue, 25% EPS growth, and strong innovation in premium marine markets.BC
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - 2025 saw sales and cash flow growth, with 2026 set for higher revenue, margins, and innovation.BC
Investor presentation3 Mar 2026 - 2025 outlook targets $5.2B–$5.6B revenue, strong cash flow, and resilience through innovation.BC
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20256 Feb 2026 - Marine leader posts Q1 sales drop but shows resilience, innovation, and strong capital returns.BC
Investor presentation6 Feb 2026 - Stable sales, record free cash flow, and robust 2025 outlook highlight market leadership.BC
Investor presentation6 Feb 2026 - Q3 2025 delivered robust sales growth, record free cash flow, and strong innovation momentum.BC
Investor presentation6 Feb 2026 - Q1 2025 sales and earnings declined, but free cash flow and Engine P&A margins improved.BC
Q1 20256 Feb 2026 - Q3 sales and earnings fell 20%+, but recurring revenue and liquidity supported results.BC
Q3 20246 Feb 2026